Design of efficient computational workflows for in silico drug repurposing

Q Vanhaelen, P Mamoshina, AM Aliper, A Artemov… - Drug Discovery …, 2017 - Elsevier
Highlights•Conceptual foundations of the drug repurposing paradigm are
reviewed.•Description of the technological trends behind the raise of in silico …

Computational drug repurposing: current trends

B Karaman, W Sippl - Current medicinal chemistry, 2019 - ingentaconnect.com
Biomedical discovery has been reshaped upon the exploding digitization of data which can
be retrieved from a number of sources, ranging from clinical pharmacology to …

DDR: efficient computational method to predict drug–target interactions using graph mining and machine learning approaches

RS Olayan, H Ashoor, VB Bajic - Bioinformatics, 2018 - academic.oup.com
Motivation Finding computationally drug–target interactions (DTIs) is a convenient strategy
to identify new DTIs at low cost with reasonable accuracy. However, the current DTI …

A novel computational approach for drug repurposing using systems biology

A Peyvandipour, N Saberian, A Shafi, M Donato… - …, 2018 - academic.oup.com
Motivation Identification of novel therapeutic effects for existing US Food and Drug
Administration (FDA)-approved drugs, drug repurposing, is an approach aimed to …

Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning

K Shameer, BS Glicksberg, R Hodos… - Briefings in …, 2018 - academic.oup.com
Increase in global population and growing disease burden due to the emergence of
infectious diseases (Zika virus), multidrug-resistant pathogens, drug-resistant cancers …

[HTML][HTML] Polypharmacology guided drug repositioning approach for SARS-CoV2

E Jamir, H Sarma, L Priyadarsinee, K Kiewhuo… - PLoS …, 2023 - journals.plos.org
Drug repurposing has emerged as an important strategy and it has a great potential in
identifying therapeutic applications for COVID-19. An extensive virtual screening of 4193 …

Drug repositioning through network pharmacology

H Ye, J Wei, K Tang, R Feuers… - Current topics in …, 2016 - ingentaconnect.com
Low drug productivity has been a significant problem of the pharmaceutical industry for
several decades even though numerous novel technologies were introduced during this …

Repurposing drugs for glioblastoma: from bench to bedside

J Basso, A Miranda, J Sousa, A Pais, C Vitorino - Cancer letters, 2018 - Elsevier
Glioblastoma multiforme is the most common, aggressive and lethal type of brain tumor. It is
a stage IV cancer disease with a poor prognosis, as the current therapeutic options (surgery …

DrugR+: a comprehensive relational database for drug repurposing, combination therapy, and replacement therapy

Y Masoudi-Sobhanzadeh, Y Omidi, M Amanlou… - Computers in biology …, 2019 - Elsevier
Drug repurposing or repositioning, which introduces new applications of the existing drugs,
is an emerging field in drug discovery scope. To enhance the success rate of the research …

How good are publicly available web services that predict bioactivity profiles for drug repurposing?

KA Murtazalieva, DS Druzhilovskiy… - SAR and QSAR in …, 2017 - Taylor & Francis
Drug repurposing provides a non-laborious and less expensive way for finding new human
medicines. Computational assessment of bioactivity profiles shed light on the hidden …